MEA Bioreactors Market

MEA Bioreactors Market Size (2024 to 2029)

The size of the Bioreactors Market in the Middle East & Africa is valued at USD 106.55 Million in 2024 and estimated to be growing at a CAGR of 7% to reach USD 149.44 Million by 2029 during the forecast period.

A bioreactor is a manufacturing device that supports a biologically active environment. It is a vessel in which a chemical process is taken place, which involves organisms or biochemically active substances derived from such organisms. These devices are being developed for use in tissue engineering or biochemical engineering. Rising Chronic disease prevalence and increasing biopharmaceutical investments will propel the growth of the market.

Rising chronic diseases prevalence, increase in the incidence of lifestyle diseases like diabetes and cancer, rising biopharmaceutical investments, increasing demand for therapeutically active vaccines, product innovation, and favorable government initiatives to develop healthcare infrastructure are the factors driving the growth of the market. Growing personalized medicine market and increasing popularity for them and increasing the popularity of single-use bioreactors among the biopharmaceutical companies will also boost the market.

Nevertheless, regulatory issues regarding single-use bioreactors, limited storage, and vulnerability to leaching may hinder the growth of the market. Likewise, large scale disposal of plastic derivatives is an environmental concern restraining the growth.

This research report segmented and sub-segmented into the following categories

• By Material: Glass, Stainless-Steel, and Single-use
• By Scale: 5L-20L, 20L-200L, 200L-1500L and Over 1500L
• By Production Size: Lab-Scale Production, Pilot-Scale Production, Full-Scale Production.
• By Control Type: Manual and Automated (MFCs)
• By End Users: R&D Departments, R&D Institutes, CRO’s, Biopharmaceutical Companies, Biopharmaceutical Manufacturers and CMO’s
• By Suppliers: OEMs, System Integrators and EPCs
• By Country: KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Noteworthy companies operating in the MEA Bioreactors Market Profiled in the Report are  Sartorius AG, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Danaher Corporation, Eppendorf AG, and significant Engineering, Procurement and Construction (EPC) players included in this report are Amec Foster Wheeler plc., Fluor Corporation,  Jacobs Engineering Group Inc., M+W Group, PM Group, and Technip S.A.